Gliptiwak 50mg Tablet
Marketer
Hanuchem Laboratories
Salt Composition
Vildagliptin (50mg)
Overview Gliptiwak 50mg Tablet
DiabetiCare 50mg tablets are indicated for managing type 2 diabetes. Optimal blood glucose control is achieved through concurrent implementation of a balanced diet and regular physical activity, thereby mitigating the risk of severe diabetic complications such as renal impairment and vision loss. DiabetiCare 50mg tablets are typically prescribed when dietary and exercise modifications, or other medications, prove inadequate for blood sugar regulation. Administration may be independent or in conjunction with other antidiabetic agents, with or without food. Dosage is individualized based on patient response and glycemic readings. Adherence to the physician's prescribed regimen is paramount. Consistent daily dosing at the same time maximizes therapeutic efficacy. Discontinuation should only occur under medical supervision. Continued adherence to the recommended dietary and exercise plan remains critical throughout treatment. Lifestyle significantly influences diabetes management. Common adverse reactions to DiabetiCare 50mg tablets include hypoglycemia, tremors, cephalgia, vertigo, lassitude, and nausea. Recognizing hypoglycemic symptoms (lightheadedness, diaphoresis, vertigo, syncope, xerostomia) and appropriate management strategies (e.g., glucose ingestion) are crucial. Persistent or concerning side effects warrant medical consultation. Prior to commencing treatment, disclose any history of renal, cardiovascular, or pancreatic disorders to your physician. Pregnant or lactating individuals should seek medical guidance before use. Potential drug interactions necessitate complete disclosure of all concurrent medications. Alcohol consumption should be moderated due to an increased hypoglycemia risk. Regular monitoring, including renal function and blood glucose levels, assesses therapeutic efficacy.
Primary Ingredients of Gliptiwak 50mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Gliptiwak 50mg Tablet
Managing type 2 diabetes
Major Benefits of Gliptiwak 50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg Gliptiwak tablet whole; do not crush, chew, or divide it. While you can take it with or without food, consistency is key—choose a regular time of day.
Common Side effects of Gliptiwak 50mg Tablet:
- Hypoglycemia (low blood glucose level)
- Tremors
- Headache
- Dizziness
- Fatigue
- Nausea
How to use Gliptiwak 50mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliptiwak 50mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Gliptiwak 50mg Tablet works:
Gliptiwak 50mg tablets are used to manage diabetes. Their mechanism of action involves stimulating insulin secretion by the pancreas while simultaneously suppressing the production of hyperglycemic hormones. The result is lower blood glucose, both before and after eating.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Gliptiwak 50mg Tablet may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Gliptiwak 50mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Gliptiwak 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 50mg Gliptiwak tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Gliptiwak 50mg tablets are generally safe for patients with kidney disease, and no dosage alteration is usually necessary. Nevertheless, individuals experiencing moderate to severe kidney impairment may need a modified dosage. Physician consultation is advised.
LiverUNSAFE
Individuals with liver impairment should likely refrain from using Gliptiwak 50mg tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Gliptiwak 50mg Tablet :
Should you forget a Gliptiwak 50mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliptiwak 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrrolidinecarbonitrile derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavior Class | Dipeptidyl peptidase-4 inhibitors |
3,018 People bought this recently